| ISELIN, N.J., Feb. 17, 2012 /PRNewswire/ -- Pharmos Corporation (OTC-PINK: PARS) today reported financial results for the fourth quarter and twelve-month period ended December 31, 2011. These results are included in the Company's Yearly Report on Form 10-K which has been filed with the SEC. Fourth Quarter Ended December 31, 2011 The Company recorded a net loss of $0.4 million, or $0.01 per share, for the fourth quarter 2011 compared to a net loss of $0.2 million, or $0.00 per share, in the fourt...continued PARS Drugs Healthcare biotech |
Friday, February 17, 2012
Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment